Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PET-Reference-Cited by-同舟云学术

Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PET

Published:2024-04 Issue:4 Volume:42 Page:115.e9-115.e16
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Huebner Nicolai A.^ORCID,Wasinger Gabriel,Rajwa Pawel,Resch Irene,Korn Stephan,Rasul Sazan,Baltzer Pascal,Prüger Larissa,Rauschmeier Andreas,Seitz Christian,Comperat Eva,Shariat Shahrokh F.,Grubmüller Bernhard

Funder

Medizinische Universität Wien

European Commission

Publisher

Elsevier BV

Reference31 articles.

1. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2021

2. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer;Roach;Int J Radiat Oncol Biol Phys,1994

3. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores;Briganti;Eur Urol,2012

4. Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer;Gandaglia;Eur Urol,2017

5. A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies;Gandaglia;Eur Urol,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can nomograms accurately predict lymph node metastasis in high-risk prostate cancer patients receiving definitive radiotherapy in the PSMA-PET/CT era?—Time to burry the hatchet;Urologic Oncology: Seminars and Original Investigations;2024-04

2. Current status and therapeutic value of extended pelvic lymph node dissection during radical prostatectomy for prostate cancer;Prostate International;2024-03